STEVENS CAPITAL MANAGEMENT LP - AVALANCHE BIOTECHNOLOGIES IN ownership

Back to all holdings Add to watchlist

AVALANCHE BIOTECHNOLOGIES IN's ticker is AAVL and the CUSIP is 05337G107.

Links
Filings
External links
Quarter-by-quarter ownership
STEVENS CAPITAL MANAGEMENT LP ownership history of AVALANCHE BIOTECHNOLOGIES IN
ValueSharesWeighting
Q1 2016$66,000
-24.1%
12,685
+20.0%
0.00%
-25.0%
Q3 2015$87,000–10,570–0.00%–
 Download
Other shareholders

There were no reported owners of AVALANCHE BIOTECHNOLOGIES IN in Q2 2016.

NameSharesValueWeighting ↓
View complete list of AVALANCHE BIOTECHNOLOGIES IN shareholders